» Articles » PMID: 8316295

Three-dimensional Structure of the Human Class II Histocompatibility Antigen HLA-DR1

Overview
Journal Nature
Specialty Science
Date 1993 Jul 1
PMID 8316295
Citations 593
Authors
Affiliations
Soon will be listed here.
Abstract

The three-dimensional structure of the class II histocompatibility glycoprotein HLA-DR1 from human B-cell membranes has been determined by X-ray crystallography and is similar to that of class I HLA. Peptides are bound in an extended conformation that projects from both ends of an 'open-ended' antigen-binding groove. A prominent non-polar pocket into which an 'anchoring' peptide side chain fits is near one end of the binding groove. A dimer of the class II alpha beta heterodimers is seen in the crystal forms of HLA-DR1, suggesting class II HLA dimerization as a mechanism for initiating the cytoplasmic signalling events in T-cell activation.

Citing Articles

Unveiling MHC- Polymorphism Within the Western Balkan Salmonid Hotspot: Preliminary Outcomes from Native Trouts of Ohrid Lake and the Drin-Skadar Drainage (Albania).

Talarico L, Rakaj A, Tancioni L Biology (Basel). 2025; 13(12.

PMID: 39765727 PMC: 11673393. DOI: 10.3390/biology13121060.


Koala MHCII association with chlamydia infertility remains equivocal: a need for new research approaches.

Kidd A, Casteriano A, Krockenberger M, Higgins D, Wright B Sci Rep. 2024; 14(1):31074.

PMID: 39730801 PMC: 11681110. DOI: 10.1038/s41598-024-82217-w.


Progression to type 1 diabetes in the DPT-1 and TN07 clinical trials is critically associated with specific residues in HLA-DQA1-B1 heterodimers.

Zhao L, Papadopoulos G, Skyler J, Pugliese A, Parikh H, Kwok W Diabetologia. 2024; 67(11):2481-2493.

PMID: 39354095 PMC: 11519105. DOI: 10.1007/s00125-024-06274-6.


Energy landscapes of peptide-MHC binding.

Collesano L, Luksza M, Lassig M PLoS Comput Biol. 2024; 20(9):e1012380.

PMID: 39226310 PMC: 11398667. DOI: 10.1371/journal.pcbi.1012380.


The Art of Bioimmunogenomics (BIGs) 5.0 in CAR-T Cell Therapy for Lymphoma Management.

Anurogo D, Luthfiana D, Anripa N, Fauziah A, Soleha M, Rahmah L Adv Pharm Bull. 2024; 14(2):314-330.

PMID: 39206402 PMC: 11347730. DOI: 10.34172/apb.2024.034.